We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+14.73%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.51B
AUM Growth
-$25.3M
Cap. Flow
-$166M
Cap. Flow %
-11.02%
Top 10 Hldgs %
21.48%
Holding
1,502
New
400
Increased
305
Reduced
321
Closed
403

Top Buys

Rank Stock Value
1
VIPS icon
Vipshop
VIPS
+$11.8M
2
EDU icon
New Oriental
EDU
+$11.7M
3
LI icon
Li Auto
LI
+$10.4M
4
HES
Hess
HES
+$9.96M
5
ACMR icon
ACM Research
ACMR
+$7.73M

Sector Composition

Rank Sector Weight
1 Technology 14.24%
2 Consumer Discretionary 12.06%
3 Healthcare 10.13%
4 Industrials 10.12%
5 Energy 5.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCCC icon
1026
C4 Therapeutics
CCCC
$400M
$100K 0.01%
17,749
-33,400
-65% -$76.2K
CMBM
1027
DELISTED
Cambium Networks
CMBM
$100K 0.01%
+16,660
New +$82K
DSX icon
1028
Diana Shipping
DSX
$296M
$99.9K 0.01%
+33,639
New +$93K
PLYA
1029
DELISTED
Playa Hotels & Resorts
PLYA
$99.5K 0.01%
11,500
-14,800
-56% -$111K
IOVA icon
1030
Iovance Biotherapeutics
IOVA
$2.9B
$97.6K 0.01%
+12,000
New +$62.8K
APPS icon
1031
Digital Turbine
APPS
$1.74B
$96.7K 0.01%
+14,100
New +$78.7K
HNRG icon
1032
Hallador Energy
HNRG
$748M
$95.1K 0.01%
+10,758
New +$136K
AOUT icon
1033
American Outdoor Brands
AOUT
$160M
$93.5K 0.01%
11,135
+635
+6% +$5.46K
CRBU icon
1034
Caribou Biosciences
CRBU
$165M
$92.4K 0.01%
+16,134
New +$79.8K
PUMP icon
1035
ProPetro Holding
PUMP
$1.43B
$92.2K 0.01%
+11,003
New +$104K
ESPR
1036
DELISTED
Esperion Therapeutics
ESPR
$89.1K 0.01%
+29,791
New +$38.6K
LILAK icon
1037
Liberty Latin America Class C
LILAK
$1.65B
$88.6K 0.01%
13,276
-17,258
-57% -$112K
HBIO icon
1038
Harvard Bioscience
HBIO
$28.8M
$88.4K 0.01%
1,653
-307
-16% -$13.9K
QUCY
1039
Quantum Cyber N.V.
QUCY
$31.6M
$87K 0.01%
+1,875
New +$133K
BCOV
1040
DELISTED
Brightcove, Inc.
BCOV
$85K 0.01%
+32,800
New +$88K
TAST
1041
DELISTED
Carrols Restaurant Group, Inc.
TAST
$83.3K 0.01%
+10,568
New +$72K
EEX
1042
DELISTED
Emerald Holding
EEX
$83K 0.01%
+13,875
New +$72.9K
AMPY icon
1043
Amplify Energy
AMPY
$172M
$82.4K 0.01%
13,900
+700
+5% +$4.52K
SOS
1044
CALL
SOS Limited
SOS
$14.4M
$82.3K 0.01%
1,193
IRD
1045
Opus Genetics
IRD
$302M
$80.3K 0.01%
26,677
+8,681
+48% +$25.7K
RLGT icon
1046
Radiant Logistics
RLGT
$390M
$79K 0.01%
11,900
-9,900
-45% -$60K
SLRN
1047
DELISTED
ACELYRIN
SLRN
$78.4K 0.01%
+10,506
New +$89.7K
LONA
1048
LeonaBio Inc
LONA
$70.5M
$76.4K 0.01%
3,142
-50
-2% -$887
SBSW icon
1049
Sibanye-Stillwater
SBSW
$7.55B
$75.9K 0.01%
+13,984
New +$72.3K
LENZ
1050
LENZ Therapeutics
LENZ
$168M
$74.9K 0.01%
4,083
-43
-1% -$710

Similar funds

Prelude Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Prelude Capital Management held 1,502 positions worth $1.51B, down 1.6% from $1.53B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Prelude Capital Management withdrew a net $166M in Q4 2023, closing 403 positions and reducing 321 holdings. Its most notable exit was Activision Blizzard, an estimated $20.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Prelude Capital Management opened a new position in New Oriental worth $12.4M.

  • Prelude Capital Management's largest Q4 2023 buy was New Oriental: 168,713 shares worth $12.4M.
  • Prelude Capital Management added most to Vipshop in Q4 2023, an estimated $11.8M increase.
  • Prelude Capital Management's biggest Q4 2023 reduction was NVIDIA, cutting an estimated $7.3M.
  • Prelude Capital Management fully exited Activision Blizzard in Q4 2023, selling an estimated $20.8M.
  • Prelude Capital Management's ten largest holdings make up 21% of its $1.51B portfolio in Q4 2023.
  • Prelude Capital Management opened 400 new positions and closed 403 in Q4 2023.
  • Prelude Capital Management's portfolio value fell 1.6% quarter-over-quarter to $1.51B.

Based on Prelude Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.